13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 12 managers

Reported value

$509.8M

Holders

12

+2 new · −0 exited

Holders’ est. mark

$40.9M

Price effect on 8 books still in the name

Largest holder

$368M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC350.1K$368M$30.4MAdded$37.3M
DANSKE BANK A/S67.7K$71.1M$4.8MAdded$19M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main46K$48.4M$4.08MAdded$824.8K
Employees Provident Fund Board8.5K$8.93M$752.6KAdded$752.6K
Swiss Life Asset Management Ltd7.97K$8.37M$558.2KAdded$2.3M
ONTARIO TEACHERS PENSION PLAN BOARD2.05K$2.16M$181.6KCut−$187K
Ramiah Investment Group788$828.2KNew
Leonteq Securities AG765$804K$67.7KAdded$65.8K
Emergent Wealth Advisors, LLC524$586.5K$81.8KAdded$84.1K
FLAGSHIP HARBOR ADVISORS, LLC252$264.9KHeld
National Philanthropic Trust201$211.3KNew
Prestige Wealth Management Group LLC102$107.2KHeld

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.